Colorado Capital Management’s Gyre Therapeutics GYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,278	Closed	-$16K	–	80
2023 Q3	$16K	Hold	2,278	–	–	0.01%	80
2023 Q2	$12K	Hold	2,278	–	–	0.01%	76
2023 Q1	$7K	Sell	2,278 -2,277	-50%	-$8.65K	0.01%	77
2022 Q4	$18K	Buy	4,555 +2,727	+149%	+$11.1K	0.02%	75
2022 Q3	$7K	Hold	1,828	–	–	0.01%	72
2022 Q2	$24K	Hold	1,828	–	–	0.02%	79
2022 Q1	$9K	Hold	1,828	–	–	0.01%	78
2021 Q4	$12K	Hold	1,828	–	–	0.01%	79
2021 Q3	$56K	Hold	1,828	–	–	0.04%	72
2021 Q2	$59K	Hold	1,828	–	–	0.04%	74
2021 Q1	$69K	Hold	1,828	–	–	0.05%	73
2020 Q4	$87K	Hold	1,828	–	–	0.06%	73
2020 Q3	$59K	Hold	1,828	–	–	0.05%	69
2020 Q2	$80K	Hold	1,828	–	–	0.07%	73
2020 Q1	$59K	Buy	+1,828	New	+$84K	0.05%	74
2017 Q1	–	Sell	-697	Closed	-$50K	–	71
2016 Q4	$50K	Hold	697	–	–	0.05%	66
2016 Q3	$95K	Hold	697	–	–	0.09%	63
2016 Q2	$120K	Hold	697	–	–	0.12%	61
2016 Q1	$131K	Hold	697	–	–	0.13%	64
2015 Q4	$245K	Buy	+697	New	+$274K	0.27%	55